Sun Pharma gross sales up 16 per cent for Q3FY19 results
The company's India sales is at ₹ 2,235 crores, growth of seven per cent while the US finished dosage sales at $ 362 million up by…
Author
Ipca Laboratories Q3 net jumps 52 pc to ₹ 160.18 cr
The company had posted a net profit of ₹ 105.58 crore for the same period of previous fiscal.
11th Asia Pharma Expo 2019 offered business networking for 12,800 trade professionals
The pharma exhibition displayed latest pharma manufacturing technologies ever in Bangladesh pharmaceutical industry
Re-Building Indian Pharma Inc
PM Modi's 'Make in India' campaign highlights pharma as one of the key sectors for growth but it is essential to first rebuild…
IPM clocks Rs 7097 Cr in Aug 2014
10 therapies have outgrown the IPM growth and six therapies have double digit growths
‘Our products meet the statutory and regulatory requirements of the EU’
More than five decades old, Mumbai-based manufacturer of laboratory/ magnetic stirrers and centrifuges, and blood bank…
IPM clocks Rs 7161 crores in July 2014
From therapy perspective, 12 therapies have outgrown the IPM growth
Express Pharma hosts Idea Exchange with Dr Kenneth Thorpe on prevention of NCDs
Dr Shashank Joshi, President, Indian Diabetic Association and Dr Ratna Devi, CEO, DakshamA Health & Education were also part…
IPM garners Rs 6636 crores in June
The Mumbai market grew the highest at 24.3 per cent followed by Vidarbha at 21.3 per cent
Why are Indian generics under attack? One view from America
Roger Bate puts forth his views on the quality of generic drugs in India and opines that the CDSCO, the main regulator should be…